Versant Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$973 Buy
+31
New +$1.31K ﹤0.01% 2646
2023
Q2
Sell
-46
Closed -$705 2072
2023
Q1
$705 Hold
46
﹤0.01% 1530
2022
Q4
$617 Sell
46
-19
-29% -$255 ﹤0.01% 1405
2022
Q3
$1K Buy
+65
New +$1.12K ﹤0.01% 1308
2022
Q1
Sell
-48
Closed -$1K 1580
2021
Q4
$1K Buy
48
+31
+182% +$662 ﹤0.01% 1321
2021
Q3
$0 Sell
17
-55
-76% -$1.32K ﹤0.01% 1554
2021
Q2
$2K Hold
72
﹤0.01% 1152
2021
Q1
$2K Buy
72
+55
+324% +$1.24K ﹤0.01% 1262
2020
Q4
$0 Sell
17
-200
-92% -$3.68K ﹤0.01% 1478
2020
Q3
$3K Sell
217
-198
-48% -$4.22K ﹤0.01% 1000
2020
Q2
$10K Sell
415
-157
-27% -$3.9K ﹤0.01% 630
2020
Q1
$13K Buy
572
+555
+3,265% +$13.6K 0.01% 490
2019
Q4
$0 Buy
17
+10
+143% +$232 ﹤0.01% 1521
2019
Q3
$0 Sell
7
-43
-86% -$1.18K ﹤0.01% 1532
2019
Q2
$1K Hold
50
﹤0.01% 1304
2019
Q1
$1K Sell
50
-56
-53% -$1.74K ﹤0.01% 1473
2018
Q4
$3K Hold
106
﹤0.01% 1179
2018
Q3
$4K Hold
106
﹤0.01% 1163
2018
Q2
$4K Hold
106
﹤0.01% 1162
2018
Q1
$4K Hold
106
﹤0.01% 1144
2017
Q4
$3K Hold
106
﹤0.01% 1261
2017
Q3
$3K Hold
106
﹤0.01% 1188
2017
Q2
$3K Hold
106
﹤0.01% 1177
2017
Q1
$2K Buy
+106
New +$2.99K ﹤0.01% 1250

Other funds holding PAHC

Versant Capital Management's PAHC Position: Q2 2026 in Review

Versant Capital Management opened a new position in Phibro Animal Health (PAHC) in Q2 2026: 31 shares worth $973. The stake represents ﹤0.01% of the portfolio and ranks #2646 among its holdings. This is a return to the name: Versant Capital Management previously reported a position in PAHC as recently as Q1 2023.

Versant Capital Management first reported a position in PAHC in Q1 2017 and has held it in 24 quarters since. The position peaked at $13K in Q1 2020. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Versant Capital Management held 31 shares of Phibro Animal Health worth $973 as of Q2 2026.
  • Phibro Animal Health was a new Versant Capital Management position in Q2 2026.
  • Phibro Animal Health made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2646 holding.
  • Versant Capital Management first reported a position in Phibro Animal Health in Q1 2017 and has held it in 24 quarters since.
  • Versant Capital Management's Phibro Animal Health position peaked at $13K in Q1 2020.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.